BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 2904825)

  • 1. A comparison of bisoprolol and atenolol in the treatment of mild to moderate hypertension.
    Lewis R; Maclean D; Ioannides C; Johnston A; McDevitt DG
    Br J Clin Pharmacol; 1988 Jul; 26(1):53-9. PubMed ID: 2904825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized double-blind study of bisoprolol versus atenolol in mild to moderate essential hypertension.
    Dixon MS; Thomas P; Sheridan DJ
    Eur J Clin Pharmacol; 1990; 38(1):21-4. PubMed ID: 1970298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind comparison of the cardioselective beta-blockers bisoprolol and atenolol in hypertension: the Bisoprolol International Multicenter Study (BIMS).
    Bühler FR; Berglund G; Anderson OK; Brunner HR; Scherrer U; van Brummelen P; Distler A; Philipp T; Fogari R; Mimran A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S122-7. PubMed ID: 2439782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of bisoprolol and atenolol in patients with mild to moderate hypertension: a double-blind, parallel group international multicentre study.
    Lithell H; Selinus I; Hosie J; Frithz G; Weiner L
    Eur Heart J; 1987 Dec; 8 Suppl M():55-64. PubMed ID: 2967186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the effects of bisoprolol and atenolol on lipoprotein concentrations and blood pressure.
    Lithell H; Weiner L; Selinus I; Vessby B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S128-33. PubMed ID: 2439783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of once daily bisoprolol in stable angina pectoris: an objective comparison with atenolol and long term follow-up.
    Kohli RS; Khurmi NS; Kardash MM; Hughes LO; Lahiri A; Raftery EB
    Eur Heart J; 1985 Oct; 6(10):845-50. PubMed ID: 2866960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of chronic stable angina with once-daily bisoprolol or atenolol and long-term efficacy of bisoprolol.
    Kohli RS; Lahiri A; Raftery EB
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S148-53. PubMed ID: 2439787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
    Ruilope LM
    Am J Hypertens; 1994 Feb; 7(2):129-36. PubMed ID: 7910028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the antihypertensive effects of betaxolol to atenolol.
    Mroczek WJ; Burris JF; Hogan LB; Citron DC; Barker AH; McDonald RH
    Am J Cardiol; 1988 Apr; 61(10):807-11. PubMed ID: 2895577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized double-blind study of atenolol and celiprolol in mild to moderate hypertension.
    Silke B; Rosenthal F; Taylor S
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S122-6. PubMed ID: 2427841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris.
    Dorow P; Bethge H; Tönnesmann U
    Eur J Clin Pharmacol; 1986; 31(2):143-7. PubMed ID: 2879733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
    Sourgens H; Schmidt J; Derendorf H
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind comparison of bisoprolol and atenolol in patients with essential hypertension.
    Wheeldon NM; MacDonald TM; Prasad N; Maclean D; Peebles L; McDevitt DG
    QJM; 1995 Aug; 88(8):565-70. PubMed ID: 7648243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents.
    Neutel JM; Smith DH; Ram CV; Kaplan NM; Papademetriou V; Fagan TC; Lefkowitz MP; Kazempour MK; Weber MA
    Am J Med; 1993 Feb; 94(2):181-7. PubMed ID: 8430713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and antihypertensive efficacy of carvedilol and atenolol alone and in combination with hydrochlorothiazide.
    Widmann L; van der Does R; Hörrmann M; Machwirth M
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S143-6. PubMed ID: 1974505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of carvedilol with atenolol in the treatment of mild-to-moderate essential hypertension. INT-CAR-07 (U.K.) Study Group.
    Young PH
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S82-5. PubMed ID: 1378155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of bisoprolol and atenolol on glucose metabolism in hypertensive patients with non-insulin-dependent diabetes mellitus].
    Vulpis V; Antonacci A; Prandi P; Bokor D; Pirrelli A
    Minerva Med; 1991 Apr; 82(4):189-93. PubMed ID: 1673233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive effects of bisoprolol during once daily administration in patients with essential hypertension. A dose-ranging study with parallel groups.
    Weiner L; Frithz G
    Eur J Clin Pharmacol; 1986; 29(5):517-21. PubMed ID: 2869951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled study of atenolol in treatment of hypertension.
    Hansson L; Aberg H; Karlberg BE; Westerlund A
    Br Med J; 1975 May; 2(5967):367-70. PubMed ID: 236810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.